UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3971-3979

2013

Volltextzugriff (PDF)

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4733-4740

2009

Volltextzugriff (PDF)

Leveraging external data in the design and analysis of clinical trials in neuro-oncology

The lancet oncology, 2021-10, Vol.22 (10), p.e456-e465

2021

Volltextzugriff (PDF)

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

Neuro-oncology (Charlottesville, Va.), 2015-01, Vol.17 (1), p.116-121

2015

Volltextzugriff (PDF)

Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

Journal of clinical oncology, 2006-12, Vol.24 (36), p.5711-5715

2006

Volltextzugriff (PDF)

Intracranial dural metastases

Cancer, 2009-05, Vol.115 (9), p.1947-1953

2009

Volltextzugriff (PDF)

Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4730-4735

2007

Volltextzugriff (PDF)

Patterns of Failure After Concurrent Bevacizumab and Hypofractionated Stereotactic Radiation Therapy for Recurrent High-Grade Glioma

International journal of radiation oncology, biology, physics, 2013-03, Vol.85 (3), p.636-642

2013

Volltextzugriff (PDF)

Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4570-4574

2006

Volltextzugriff (PDF)

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

International journal of radiation oncology, biology, physics, 2009-09, Vol.75 (1), p.156-163

2009

Volltextzugriff (PDF)

Therapeutic challenges in primary CNS lymphoma

Lancet neurology, 2009-06, Vol.8 (6), p.581-592

2009

Volltextzugriff (PDF)

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

Neuro-oncology (Charlottesville, Va.), 2017-01, Vol.19 (1), p.89-98

2017

Volltextzugriff (PDF)

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials

Clinical cancer research, 2017-10, Vol.23 (19), p.5745-5756

2017

Volltextzugriff (PDF)

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3861-3867

2009

Volltextzugriff (PDF)

Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5034-5043

2005

Volltextzugriff (PDF)

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches

Radiation oncology (London, England), 2011-01, Vol.6 (1), p.2-2, Article 2

2011

Volltextzugriff (PDF)

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

Neurology, 2007-09, Vol.69 (11), p.1178-1182

2007

Volltextzugriff (PDF)

Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy

Current neurology and neuroscience reports, 2013-05, Vol.13 (5), p.347-347, Article 347

2013

Volltextzugriff (PDF)

The utility of body FDG PET in staging primary central nervous system lymphoma

Neuro-oncology (Charlottesville, Va.), 2008-04, Vol.10 (2), p.223-228

2008

Volltextzugriff (PDF)

Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio

Neuro-oncology (Charlottesville, Va.), 2018-03, Vol.20 (4), p.557-566

2018

Volltextzugriff (PDF)

Capecitabine therapy of central nervous system metastases from breast cancer

Journal of neuro-oncology, 2007-11, Vol.85 (2), p.223-227

2007

Volltextzugriff (PDF)

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)

Journal of neuro-oncology, 2009-03, Vol.92 (1), p.99-105

2009

Volltextzugriff (PDF)

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

Leukemia & lymphoma, 2013-01, Vol.54 (1), p.58-61

2013

Volltextzugriff (PDF)

Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients

Neurology, 2006-06, Vol.66 (11), p.1763-1765

2006

Volltextzugriff (PDF)

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

Annals of clinical and translational neurology, 2020-04, Vol.7 (4), p.429-436

2020

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

Englisch
(253)
Japanisch
(43)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(181)
Life Sciences & Biomedicine
(152)
Science & Technology
(152)
Oncology
(129)
Female
(112)
Male
(106)
Middle Aged
(99)
Adult
(94)
Aged
(89)
Clinical Neurology
(80)
Neurosciences & Neurology
(80)
Biological And Medical Sciences
(63)
Medical Sciences
(63)
Neurology
(60)
Brain Neoplasms - Drug Therapy
(58)
Treatment Outcome
(52)
Chemotherapy
(45)
Aged, 80 And Over
(37)
Retrospective Studies
(35)
Antineoplastic Agents - Therapeutic Use
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Neuro-Oncology
(31)
Neuro-Oncology
(31)
Journal Of Clinical Oncology
(27)
Cancer
(25)
Cancer Treatment And Research
(22)
Brain Metastases
(12)
Clinical Cancer Research
(12)
Leptomeningeal Metastases
(10)
Neurology
(9)
Current Neurology And Neuroscience Reports
(8)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Leveraging external data in the design and analysis of clinical trials in neuro-oncology

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

Intracranial dural metastases

Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

Patterns of Failure After Concurrent Bevacizumab and Hypofractionated Stereotactic Radiation Therapy for Recurrent High-Grade Glioma

Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

Therapeutic challenges in primary CNS lymphoma

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy

The utility of body FDG PET in staging primary central nervous system lymphoma

Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio

Capecitabine therapy of central nervous system metastases from breast cancer

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

Suchergebnisse filtern